10q10k10q10k.net

vs

Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and NOVARTIS AG (NVS), based on the latest 10-Q / 10-K filings. Click either name above to swap in a different company.

Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.

Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history — bar widths are scaled to the larger of the two companies so you can eyeball the size gap and growth trajectory without doing math. Quarters aligned by calendar period (report date) so offset fiscal years line up.

Revenue
ACAD
ACAD
NVS
NVS
Q4 25
$284.0M
Q3 25
$278.6M
Q2 25
$264.6M
Q1 25
$244.3M
Q4 24
$259.6M
Q3 24
$250.4M
Q2 24
$242.0M
Q1 24
$205.8M
Net Profit
ACAD
ACAD
NVS
NVS
Q4 25
$273.6M
Q3 25
$71.8M
Q2 25
$26.7M
Q1 25
$19.0M
Q4 24
$143.7M
Q3 24
$32.8M
Q2 24
$33.4M
Q1 24
$16.6M
Gross Margin
ACAD
ACAD
NVS
NVS
Q4 25
90.8%
Q3 25
92.2%
Q2 25
92.2%
Q1 25
91.7%
Q4 24
91.6%
Q3 24
92.5%
Q2 24
92.5%
Q1 24
88.8%
Operating Margin
ACAD
ACAD
NVS
NVS
Q4 25
6.1%
Q3 25
12.8%
Q2 25
12.2%
Q1 25
7.9%
Q4 24
59.1%
Q3 24
12.6%
Q2 24
12.6%
Q1 24
7.4%
Net Margin
ACAD
ACAD
NVS
NVS
Q4 25
96.3%
Q3 25
25.8%
Q2 25
10.1%
Q1 25
7.8%
Q4 24
55.4%
Q3 24
13.1%
Q2 24
13.8%
Q1 24
8.0%
EPS (diluted)
ACAD
ACAD
NVS
NVS
Q4 25
$1.61
Q3 25
$0.42
Q2 25
$0.16
Q1 25
$0.11
Q4 24
$0.86
Q3 24
$0.20
Q2 24
$0.20
Q1 24
$0.10

Financial Flow Comparison

Sankey diagram of revenue → gross profit → operating profit → net profit for each company. Charts shown full-width and stacked so both segment hierarchies are readable side-by-side on desktop and mobile.

Related Comparisons